Morgan Stanley analyst issues OVERWEIGHT recommendation for KO on February 13, 2024 04:32AM ET. The previous analyst recommendation was Overweight.KO was trading at $59.7 at issue of the analyst recommendation.The...
Rosenblatt Securities analyst issues UNDERPERFORM recommendation for AVGO on February 12, 2024 03:00PM ET. The previous analyst recommendation was Underperform.AVGO was trading at $1264.2 at issue of the analyst recommendation.The...
Susquehanna analyst issues MARKET PERFORM recommendation for AVGO on February 12, 2024 03:00PM ET. The previous analyst recommendation was Market Perform.AVGO was trading at $1264.2 at issue of the analyst...
Rosenblatt Securities analyst issues BUY recommendation for QCOM on February 12, 2024 01:01PM ET. The previous analyst recommendation was Buy.QCOM was trading at $154.25 at issue of the analyst recommendation.The...
Oppenheimer analyst issues OUTPERFORM recommendation for WMT on February 12, 2024 01:25PM ET. The previous analyst recommendation was Outperform.WMT was trading at $169.98 at issue of the analyst recommendation.The overall...
UBS analyst issues BUY recommendation for VALE on February 12, 2024 12:00PM ET. The previous analyst recommendation was Buy.VALE was trading at $13.4301 at issue of the analyst recommendation.The overall...
UBS analyst issues UNDERPERFORM recommendation for AFRM on February 12, 2024 10:00AM ET. The previous analyst recommendation was Underperform.AFRM was trading at $45.95 at issue of the analyst recommendation.The overall...
UBS analyst issues UNDERPERFORM recommendation for AFRM on February 12, 2024 10:00AM ET. The previous analyst recommendation was Underperform.AFRM was trading at $45.95 at issue of the analyst recommendation.The overall...
Wedbush analyst issues MARKET PERFORM recommendation for AFRM on February 12, 2024 10:00AM ET. The previous analyst recommendation was Market Perform.AFRM was trading at $45.9495 at issue of the analyst...
Wolfe Research analyst issues BUY recommendation for CRM on February 12, 2024 09:00AM ET. The previous analyst recommendation was Buy.CRM was trading at $290.8075 at issue of the analyst recommendation.The...
